HITIQ Limited (HIQ.AX)

0.0530 +0.0020 (+3.92%) 收市價： 03:05PM AEST

HITIQ Limited

9-17 Raglan Street
Suite 1 Level 2 South Melbourne
Melbourne, VIC 3205
Australia
61 4 7803 8567
https://hitiq.com

版塊: Healthcare
行業: Health Information Services
全職員工: 25

高階主管

名稱	標題	支付	行使價	出生年份
Mr. Michael Dean Vegar	MD, CEO & Director	164.25k	無	無
Mr. David Erikson	Chief Technical Officer	149.09k	無	無
Mr. Thomas Laudenbach	Head of Product & Projects	104.82k	無	無
Mr. Damien Peter Hawes	Head of Commercial	148.92k	無	無
Peter Torre	Company Sec.	無	無	無

截止 2021年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 AUD。

描述

HitIQ Limited develops and commercializes concussion management technology in Australia. The company offers Nexus A9 sensor to record individual head impacts. Its Nexus software delivers a platform for measuring and managing head impact exposures, as well as allows users to quantify exposures across individual players, positions, periods, and drills. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform which identifies impairments across domains, such as hand-eye coordination, memory, and decision making. HitIQ Limited was incorporated in 2015 and is based in Melbourne, Australia.

公司管治

截至 無 止，HITIQ Limited 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。